Skip to main content
OpenTrials

Clinical trial condition

Familial Hypercholesterolemia

Explore clinical trials studying Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

78 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Familial Hypercholesterolemia trial results

Completed

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT05142722

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Synexus Clinical Research US, Inc. / Simon Williamson Clinic, PC Birmingham, Alabama, United States
  • The Center for Clinical Trials, Inc Saraland, Alabama, United States
View all 181 locations
View Trial Details
Completed

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

NCT05952856

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0093) Daphne, Alabama, United States
  • G&L Research ( Site 0043) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0087) Beverly Hills, California, United States
View all 168 locations
View Trial Details
Completed

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

NCT05425745

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +14 more
Locations
  • Site 01022 Jonesboro, Arkansas, United States
  • Site 01015 Toluca Lake, California, United States
  • Site 01009 Sarasota, Florida, United States
  • Site 01023 Boise, Idaho, United States
View all 96 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)

NCT05261126

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Westside Medical Associates of Los Angeles ( Site 0026) Beverly Hills, California, United States
  • Clinical Trials Research ( Site 0007) Sacramento, California, United States
  • National Research Institute (NRI) - Santa Ana ( Site 0024) Santa Ana, California, United States
  • Excel Medical Clinical Trials ( Site 0042) Boca Raton, Florida, United States
View all 63 locations
View Trial Details
Completed

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

NCT02808403

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Research Site Ichinomiya, Aichi-ken, Japan
  • Research Site Ichinomiya, Aichi-ken, Japan
  • Research Site Inuyama, Aichi-ken, Japan
  • Research Site Kasugai, Aichi-ken, Japan
View all 138 locations
View Trial Details

Related conditions